Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Investigation of mitochondrial metabolism in small human skeletal muscle biopsy specimens. Improvement of preparation procedure.

Fischer JC, Ruitenbeek W, Stadhouders AM, Trijbels JM, Sengers RC, Janssen AJ, Veerkamp JH.

Clin Chim Acta. 1985 Jan 15;145(1):89-99.

PMID:
3978823
2.

Familial "mitochondrial" myopathy. A myopathy associated with disordered oxidative metabolism in muscle fibres. 2. Biochemical findings.

Worsfold M, Park DC, Pennington RJ.

J Neurol Sci. 1973 Jul;19(3):261-74. No abstract available.

PMID:
4716844
3.

Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy.

Arnold DL, Taylor DJ, Radda GK.

Ann Neurol. 1985 Aug;18(2):189-96.

PMID:
4037759
4.
5.

Human skeletal muscle metabolism and morphology after temporary incomplete ischaemia.

Sjöström M, Neglén P, Fridén J, Eklöf B.

Eur J Clin Invest. 1982 Feb;12(1):69-79.

PMID:
6802655
6.

Abnormal oxidative phosphorylation in skeletal muscle mitochondria of the BIO 14.6 dystrophic Syrian hamster.

Wrogemann K, Blanchaer MC, Jacobson BE.

Recent Adv Stud Cardiac Struct Metab. 1972;1:289-93. No abstract available.

PMID:
4681465
7.

Mitochondrial creatine kinase activity in patients with disturbed energy generation in muscle mitochondria.

Smeitink J, Ruitenbeek W, Sengers R, Wevers R, van Lith T, Trijbels F.

J Inherit Metab Dis. 1994;17(1):67-73.

PMID:
8051938
8.

Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy.

Radda GK, Taylor DJ, Arnold DL.

Biochem Soc Trans. 1985 Aug;13(4):654. No abstract available.

PMID:
4029496
9.

Control of oxidative phosphorylation in rat muscle mitochondria: implications for mitochondrial myopathies.

Letellier T, Malgat M, Mazat JP.

Biochim Biophys Acta. 1993 Feb 8;1141(1):58-64.

PMID:
8382080
10.

Uraemic muscle metabolism at rest and during exercise.

Thompson CH, Kemp GJ, Barnes PR, Rajagopalan B, Styles P, Taylor DJ, Radda GK.

Nephrol Dial Transplant. 1994;9(11):1600-5.

PMID:
7870350
12.

Mitochondrial myopathies: defects in mitochondrial metabolism in human skeletal muscle.

Clark JB, Hayes DJ, Byrne E, Morgan-Hughes JA.

Biochem Soc Trans. 1983 Dec;11(6):626-7. No abstract available.

PMID:
6321262
13.

Histochemical and ultrastructural analysis of the mitochondrial changes in a familial mitochondrial myopathy.

Tassin S, Walter GF, Brucher JM, Rousseau JJ.

Neuropathol Appl Neurobiol. 1980 Sep-Oct;6(5):337-47.

PMID:
6161318
14.

[Mitochondrial myopathies].

Reichmann H, Rohkamm R, Ricker K, Mertens HG.

Dtsch Med Wochenschr. 1988 Jan 22;113(3):106-13. Review. German. No abstract available.

PMID:
2827983
15.

Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy.

Lodi R, Taylor DJ, Tabrizi SJ, Hilton-Jones D, Squier MV, Seller A, Styles P, Schapira AH.

Brain. 1998 Nov;121 ( Pt 11):2119-26.

16.

Investigation of glycosylation processes in mitochondria and microsomal membranes from human skeletal muscle.

Gasnier F, Lerme F, Rousson R, Roussouly P, Vaganay E, Louisot P, Gateau-Roesch O.

Clin Chim Acta. 1991 May 31;199(1):69-82.

PMID:
1718634
17.

Control of skeletal muscle mitochondria respiration by adenine nucleotides: differential effect of ADP and ATP according to muscle contractile type in pigs.

Gueguen N, Lefaucheur L, Fillaut M, Vincent A, Herpin P.

Comp Biochem Physiol B Biochem Mol Biol. 2005 Feb;140(2):287-97.

PMID:
15649776
18.

Quantitative analysis by 31P magnetic resonance spectroscopy of abnormal mitochondrial oxidation in skeletal muscle during recovery from exercise.

Kemp GJ, Taylor DJ, Thompson CH, Hands LJ, Rajagopalan B, Styles P, Radda GK.

NMR Biomed. 1993 Sep-Oct;6(5):302-10.

PMID:
8268062
19.

Two types of mitochondrial crystals in diseased human skeletal muscle fibers.

Farrants GW, Hovmöller S, Stadhouders AM.

Muscle Nerve. 1988 Jan;11(1):45-55.

PMID:
3340100
20.

Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats.

Schaefer WH, Lawrence JW, Loughlin AF, Stoffregen DA, Mixson LA, Dean DC, Raab CE, Yu NX, Lankas GR, Frederick CB.

Toxicol Appl Pharmacol. 2004 Jan 1;194(1):10-23.

PMID:
14728975
Items per page

Supplemental Content

Write to the Help Desk